Global Hospital Infection Prevention and Control Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027
“Global Hospital Infection Prevention and Control Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2027” is a recent report generated by MarketResearch.biz, which offers in-depth insights, revenue details, and other vital information regarding the global hospital infection prevention and control market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global hospital infection prevention and control market report has been segmented on the basis of product, antimicrobial drugs, infections, and region.
Controlling the spread of diseases and minimizing the number of healthcare-associated infections are among the primary concerns for any healthcare facility across the globe. Infection control is a series of steps that healthcare facilities and hospitals take in order to prevent the spread of infectious diseases. According to the Centers for Disease Control and Prevention in 2017, one out of every twenty hospitalized patients is affected with some form of healthcare-associated infection
Key factors expected to drive growth of the global hospital infection prevention and control market is rising prevelance of infections across the globe. In addition, increasing healthcare expenditure, growing incidence of chronic diseases, increase in healthcare utilization, and growing geriatric population are some other factors expected to drive growth of the global hospital infection prevention and control market. Furthermore, increasing hospital admissions and outpatient visits, rising number of surgical procedures, initiatives by NGO and Government to spread the awareness regarding infection prevention and management, are some other factors expected to drive growth of the target market over the forecasted period. However, strict regulation is the factors expected to hamper growth of the global hospital infection prevention and control market over the forecast period.
Trends and Opportunity:
Prominent players are focusing on partnering with various end users such as hospitals and medical laboratory in order to expand its geographical footprint is key trends witnessed in the target market, currently.
The market in North America is expected to dominate in the global hospital infection prevention and control market. This is primarily attributed to rising number of surgical procedure in countries in the region. According to the Centers for Disease Control and Prevention (CDC) approximately 300,000 cases of surgical site infections (SSIs) occurrences each year, and second most prevelance is hospital acquired infection (HAI) in the US. The market in Asia Pacific is expected to be an emerging market for the global hospital infection prevention and control market, and is expected to register highest CAGR over the forecast period, rising healthcare expenditure and growing geriatric population in countries in the region. Moreover, the markets in Europe, Latin America and Middle East & Africa are expected to register significant higher revenue growth in the global hospital infection prevention and control market over the forecast period.
GLOBAL HOSPITAL INFECTION PREVENTION AND CONTROL MARKET SEGMENTATION:
Segmentation by product:
- Infection Prevention Supplies
- Infection Prevention Equipment
- Infection Prevention Services
Segmentation by antimicrobial drugs:
- Anti-bacterial Drug
- Anti-Viral Drug
- Anti-fungal Drug
Segmentation by infections:
- Microbial infections
- Bacterial infection
- Viral Infection
- Fungal Infection
- Hospital Acquired Infection
- Central line associated bloodstream infection (CLABSI)
- Catheter associated Urinary Tract infection
- Surgical site infection
- Ventilator associated Pneumonia (VAP) infection
- Community acquired infection
- Methicillin resistant Staphylococcus aureus (MRSA) infection
- Community acquired pneumonia
Segmentation by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- 3M Company
- Becton, Dickinson and Company
- Ansell Ltd.
- Belimed AG
- Bemis Company, Inc.
- Braun Melsungen AG
- Cantel Medical Corp.
- Cardinal Health, Inc.
- Covidien plc.
- Crosstex International, Inc.
- Danaher Corp.
- Diversey, Inc.
- Johnson & Johnson
Request for TOC
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Request for Customization
Don't just take our word. We are trusted by these great companies!